thymoquinone has been researched along with Chronic Lung Injury in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, A; Huang, D; Jia, H; Jiang, X; Li, J; Li, Q; Liu, Y; Mao, M; Xia, S | 1 |
| Almatroodi, SA; Alsahli, MA; Alzohairy, MA; Khan, AA; Rahmani, AH | 1 |
| Abdulghani, MAM; Al-Attar, AR; Al-Balagi, N; Al-Gabri, NA; Al-Shargi, OYA; Al-Sobarry, M; Al-Zharani, M; Ali, AA; Alnaimat, SM; Alotaibi, A; Althunibat, OY; Mahmoud, AM; Nasr, FA; Saghir, SAM | 1 |
| Abd El-Hack, ME; Al-Gabri, NA; Al-Hashedi, SA; Al-Wajeeh, AS; El-Far, AH; El-Tarabily, KA; Khafaga, AF; Mousa, SA; Naiel, MAE; Saghir, SAM; Swelum, AA | 1 |
| Alkan, M; Arslan, M; Erkent, FD; Kılıç, Y; Kucuk, A; Mardin, B; Oktar, GL; Özer, A; Sezen, ŞC; Tosun, M; Ünal, Y | 1 |
| Kanter, M | 1 |
| Bayram, I; Isik, AF; Kati, I; Ozbek, H | 1 |
1 review(s) available for thymoquinone and Chronic Lung Injury
| Article | Year |
|---|---|
Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review.
Topics: Benzoquinones; Humans; Lung Injury; Nanoparticles; Nigella sativa | 2021 |
6 other study(ies) available for thymoquinone and Chronic Lung Injury
| Article | Year |
|---|---|
Thymoquinone ameliorates the PM2.5-induced lung injury in rats.
Topics: Animals; Apoptosis; Autophagy; Benzoquinones; Heme Oxygenase-1; Inflammation; Lung; Lung Injury; Male; NF-E2-Related Factor 2; Oxidative Stress; Particulate Matter; Rats; Rats, Wistar; Signal Transduction | 2020 |
Protective Effects of Thymoquinone, an Active Compound of
Topics: Animals; Antioxidants; Benzo(a)pyrene; Benzoquinones; Cholesterol; DNA Fragmentation; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Lipids; Lung; Lung Injury; Male; Nigella sativa; Nitric Oxide; Oxidative Stress; Pulmonary Fibrosis; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha | 2021 |
Ameliorative Effect of Thymoquinone-Loaded PLGA Nanoparticles on Chronic Lung Injury Induced by Repetitive Intratracheal Instillation of Lipopolysaccharide in Rats.
Topics: Animals; Benzoquinones; Chronic Disease; Humans; Intubation, Intratracheal; Lipopolysaccharides; Lung Injury; Male; Nanoparticles; Rats | 2021 |
Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats.
Topics: Animals; bcl-2-Associated X Protein; Benzoquinones; Hydrazones; Immunohistochemistry; Injections, Intraperitoneal; Lung Injury; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Proto-Oncogene Proteins c-bcl-2; Pyridazines; Rats; Rats, Wistar; Simendan | 2018 |
Thymoquinone attenuates lung injury induced by chronic toluene exposure in rats.
Topics: Animals; Apoptosis; Benzoquinones; Drug Evaluation, Preclinical; In Situ Nick-End Labeling; Inhalation Exposure; Lung; Lung Injury; Male; Nitric Oxide Synthase Type II; Pulmonary Surfactant-Associated Protein D; Rats; Rats, Wistar; Toluene; Up-Regulation | 2011 |
A new agent for treatment of acute respiratory distress syndrome: thymoquinone. An experimental study in a rat model.
Topics: Acute Disease; Animals; Anti-Infective Agents, Local; Benzoquinones; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethanol; Glucocorticoids; Lung; Lung Compliance; Lung Injury; Male; Methylprednisolone; Oxygen; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome | 2005 |